New study reveals that vaccines developed using mRNA might hold the key to 'off-the-shelf' cancer vaccine.
New study reveals that vaccines developed using mRNA might hold the key to ‘off-the-shelf’ cancer vaccine.
By Yashraj Sharma
Share
Save
The mass-produced COVID-19 vaccines built using the mRNA model – which were rapidly manufactured during the global pandemic – could also help the immune system recognise and attack cancer tumours, new studies have shown.
Vaccini anti-Covid a mRNA: una nuova arma contro il cancro?
Tumori: vaccino anti-Covid mRNA attiva risposta immunitaria
Tumore polmoni e melanoma, vaccini Covid Rma raddoppiano efficacia terapia immunitaria
Un inatteso effetto collaterale dei vaccini contro il COVID-19 - Il Post
